Fusion products with the ETS family of transcription factors play critical roles in the etiology of several cancers. In this issue of Structure, Hou et al. (2020) provide insight into allosteric mechanisms by which mithramycin and its analogs perturb protein-DNA interactions in higher-order complexes at a DNA enhancer site.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.str.2021.03.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!